| 1 |
32551032 | BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis. | 2020 |
1 |
| 2 |
28055975 | Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells. | 2017 Feb 21 |
3 |
| 3 |
28161489 | Antiproliferative effects of Bortezomib in endothelial cells transformed by viral G protein-coupled receptor associated to Kaposi's sarcoma. | 2017 Apr |
2 |
| 4 |
26025442 | Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment. | 2015 May 30 |
2 |
| 5 |
26378933 | Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma. | 2015 |
5 |
| 6 |
24380881 | HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib. | 2014 Apr |
2 |
| 7 |
24485799 | Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells. | 2014 Apr |
2 |
| 8 |
23064281 | Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines. | 2013 Jan |
1 |
| 9 |
23449448 | Phosphorylation of signal transducer and activator of transcription 1 reduces bortezomib-mediated apoptosis in cancer cells. | 2013 Feb 28 |
1 |
| 10 |
23716467 | Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21. | 2013 Oct |
5 |
| 11 |
23903894 | Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes. | 2013 Sep |
1 |
| 12 |
24263099 | Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation. | 2013 Nov 21 |
1 |
| 13 |
22231280 | The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma. | 2012 Jun |
1 |
| 14 |
22324515 | Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells. | 2012 Jun |
1 |
| 15 |
22559167 | Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model. | 2012 May 4 |
1 |
| 16 |
21429402 | [In vitro synergistic effect of bortezomib and pirarubicin on proliferation and apoptosis of T cell lymphoma cell line Hut-78 cells]. | 2011 Jan |
1 |
| 17 |
22087283 | The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway. | 2011 |
1 |
| 18 |
22169296 | [Mechanism associated to enhancing the sensitivity of myeloma cells U266 to bortezomib by 2-methoxyestradiol]. | 2011 Dec |
1 |
| 19 |
19608275 | Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition. | 2010 Jan |
1 |
| 20 |
20383943 | Bortezomib induces apoptosis in human neuroblastoma CHP126 cells. | 2010 Mar |
1 |
| 21 |
20397022 | Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib. | 2010 Jul |
1 |
| 22 |
19661301 | Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independent. | 2009 Aug |
1 |
| 23 |
18223318 | Proteasome inhibitor Bortezomib induces cell cycle arrest and apoptosis in cell lines derived from Ewing's sarcoma family of tumors and synergizes with TRAIL. | 2008 Apr |
1 |
| 24 |
18445700 | Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells. | 2008 Jun |
1 |
| 25 |
17762396 | Antitumor effects and drug interactions of the proteasome inhibitor bortezomib (PS341) in gastric cancer cells. | 2007 Jul |
1 |
| 26 |
16849420 | Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro. | 2006 Oct |
1 |
| 27 |
15662128 | The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells. | 2005 Jan |
1 |
| 28 |
16178003 | Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies. | 2005 Nov 1 |
1 |
| 29 |
15052205 | Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer. | 2004 Apr |
1 |
| 30 |
15131062 | Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors. | 2004 May 1 |
1 |
| 31 |
15464472 | Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis. | 2004 Oct |
1 |
| 32 |
12738242 | Clinical update: proteasome inhibitors in solid tumors. | 2003 May |
1 |
| 33 |
14688479 | Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells. | 2003 Nov-Dec |
2 |
| 34 |
11306489 | The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. | 2001 Apr 1 |
1 |
| 35 |
11740818 | Novel therapies targeting the myeloma cell and its bone marrow microenvironment. | 2001 Dec |
1 |